1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PI3K
1.2.3 Janus Kinase Therapies (Inhibitors)
1.2.4 PI3K Therapies (Inhibitors)
1.2.5 Signal Transduction Biomarkers for JAK and PI3K
1.3 Market by Application
1.3.1 Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Inflammatory Diseases
1.3.4 Cardiac Ailments
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global JAK and PI3K Signaling Pathway Market Perspective (2017-2028)
2.2 JAK and PI3K Signaling Pathway Growth Trends by Region
2.2.1 JAK and PI3K Signaling Pathway Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 JAK and PI3K Signaling Pathway Historic Market Size by Region (2017-2022)
2.2.3 JAK and PI3K Signaling Pathway Forecasted Market Size by Region (2023-2028)
2.3 JAK and PI3K Signaling Pathway Market Dynamics
2.3.1 JAK and PI3K Signaling Pathway Industry Trends
2.3.2 JAK and PI3K Signaling Pathway Market Drivers
2.3.3 JAK and PI3K Signaling Pathway Market Challenges
2.3.4 JAK and PI3K Signaling Pathway Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue
3.1.1 Global Top JAK and PI3K Signaling Pathway Players by Revenue (2017-2022)
3.1.2 Global JAK and PI3K Signaling Pathway Revenue Market Share by Players (2017-2022)
3.2 Global JAK and PI3K Signaling Pathway Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by JAK and PI3K Signaling Pathway Revenue
3.4 Global JAK and PI3K Signaling Pathway Market Concentration Ratio
3.4.1 Global JAK and PI3K Signaling Pathway Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by JAK and PI3K Signaling Pathway Revenue in 2021
3.5 JAK and PI3K Signaling Pathway Key Players Head office and Area Served
3.6 Key Players JAK and PI3K Signaling Pathway Product Solution and Service
3.7 Date of Enter into JAK and PI3K Signaling Pathway Market
3.8 Mergers & Acquisitions, Expansion Plans
4 JAK and PI3K Signaling Pathway Breakdown Data by Type
4.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Type (2017-2022)
4.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2023-2028)
5 JAK and PI3K Signaling Pathway Breakdown Data by Application
5.1 Global JAK and PI3K Signaling Pathway Historic Market Size by Application (2017-2022)
5.2 Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America JAK and PI3K Signaling Pathway Market Size (2017-2028)
6.2 North America JAK and PI3K Signaling Pathway Market Size by Type
6.2.1 North America JAK and PI3K Signaling Pathway Market Size by Type (2017-2022)
6.2.2 North America JAK and PI3K Signaling Pathway Market Size by Type (2023-2028)
6.2.3 North America JAK and PI3K Signaling Pathway Market Share by Type (2017-2028)
6.3 North America JAK and PI3K Signaling Pathway Market Size by Application
6.3.1 North America JAK and PI3K Signaling Pathway Market Size by Application (2017-2022)
6.3.2 North America JAK and PI3K Signaling Pathway Market Size by Application (2023-2028)
6.3.3 North America JAK and PI3K Signaling Pathway Market Share by Application (2017-2028)
6.4 North America JAK and PI3K Signaling Pathway Market Size by Country
6.4.1 North America JAK and PI3K Signaling Pathway Market Size by Country (2017-2022)
6.4.2 North America JAK and PI3K Signaling Pathway Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe JAK and PI3K Signaling Pathway Market Size (2017-2028)
7.2 Europe JAK and PI3K Signaling Pathway Market Size by Type
7.2.1 Europe JAK and PI3K Signaling Pathway Market Size by Type (2017-2022)
7.2.2 Europe JAK and PI3K Signaling Pathway Market Size by Type (2023-2028)
7.2.3 Europe JAK and PI3K Signaling Pathway Market Share by Type (2017-2028)
7.3 Europe JAK and PI3K Signaling Pathway Market Size by Application
7.3.1 Europe JAK and PI3K Signaling Pathway Market Size by Application (2017-2022)
7.3.2 Europe JAK and PI3K Signaling Pathway Market Size by Application (2023-2028)
7.3.3 Europe JAK and PI3K Signaling Pathway Market Share by Application (2017-2028)
7.4 Europe JAK and PI3K Signaling Pathway Market Size by Country
7.4.1 Europe JAK and PI3K Signaling Pathway Market Size by Country (2017-2022)
7.4.2 Europe JAK and PI3K Signaling Pathway Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size (2017-2028)
8.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type
8.2.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2017-2022)
8.2.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Type (2023-2028)
8.2.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Type (2017-2028)
8.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application
8.3.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2017-2022)
8.3.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Application (2023-2028)
8.3.3 Asia-Pacific JAK and PI3K Signaling Pathway Market Share by Application (2017-2028)
8.4 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region
8.4.1 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2017-2022)
8.4.2 Asia-Pacific JAK and PI3K Signaling Pathway Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America JAK and PI3K Signaling Pathway Market Size (2017-2028)
9.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type
9.2.1 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2017-2022)
9.2.2 Latin America JAK and PI3K Signaling Pathway Market Size by Type (2023-2028)
9.2.3 Latin America JAK and PI3K Signaling Pathway Market Share by Type (2017-2028)
9.3 Latin America JAK and PI3K Signaling Pathway Market Size by Application
9.3.1 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2017-2022)
9.3.2 Latin America JAK and PI3K Signaling Pathway Market Size by Application (2023-2028)
9.3.3 Latin America JAK and PI3K Signaling Pathway Market Share by Application (2017-2028)
9.4 Latin America JAK and PI3K Signaling Pathway Market Size by Country
9.4.1 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2017-2022)
9.4.2 Latin America JAK and PI3K Signaling Pathway Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size (2017-2028)
10.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type
10.2.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2017-2022)
10.2.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Type (2023-2028)
10.2.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Type (2017-2028)
10.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application
10.3.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2017-2022)
10.3.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Application (2023-2028)
10.3.3 Middle East & Africa JAK and PI3K Signaling Pathway Market Share by Application (2017-2028)
10.4 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country
10.4.1 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2017-2022)
10.4.2 Middle East & Africa JAK and PI3K Signaling Pathway Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare Pharmaceuticals
11.1.1 Bayer HealthCare Pharmaceuticals Company Details
11.1.2 Bayer HealthCare Pharmaceuticals Business Overview
11.1.3 Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.1.4 Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.1.5 Bayer HealthCare Pharmaceuticals Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie JAK and PI3K Signaling Pathway Introduction
11.2.4 AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.2.5 AbbVie Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca JAK and PI3K Signaling Pathway Introduction
11.3.4 AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.3.5 AstraZeneca Recent Developments
11.4 Curis
11.4.1 Curis Company Details
11.4.2 Curis Business Overview
11.4.3 Curis JAK and PI3K Signaling Pathway Introduction
11.4.4 Curis Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.4.5 Curis Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo JAK and PI3K Signaling Pathway Introduction
11.5.4 Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.5.5 Daiichi Sankyo Recent Developments
11.6 Exelixis
11.6.1 Exelixis Company Details
11.6.2 Exelixis Business Overview
11.6.3 Exelixis JAK and PI3K Signaling Pathway Introduction
11.6.4 Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.6.5 Exelixis Recent Developments
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech JAK and PI3K Signaling Pathway Introduction
11.7.4 Genentech Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.7.5 Genentech Recent Developments
11.8 Infinity Pharmaceuticals
11.8.1 Infinity Pharmaceuticals Company Details
11.8.2 Infinity Pharmaceuticals Business Overview
11.8.3 Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.8.4 Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.8.5 Infinity Pharmaceuticals Recent Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Company Details
11.9.2 Merck & Co. Business Overview
11.9.3 Merck & Co. JAK and PI3K Signaling Pathway Introduction
11.9.4 Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.9.5 Merck & Co. Recent Developments
11.10 Rigel Pharmaceuticals
11.10.1 Rigel Pharmaceuticals Company Details
11.10.2 Rigel Pharmaceuticals Business Overview
11.10.3 Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.10.4 Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.10.5 Rigel Pharmaceuticals Recent Developments
11.11 TG Therapeutics
11.11.1 TG Therapeutics Company Details
11.11.2 TG Therapeutics Business Overview
11.11.3 TG Therapeutics JAK and PI3K Signaling Pathway Introduction
11.11.4 TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.11.5 TG Therapeutics Recent Developments
11.12 Sanofi Oncology
11.12.1 Sanofi Oncology Company Details
11.12.2 Sanofi Oncology Business Overview
11.12.3 Sanofi Oncology JAK and PI3K Signaling Pathway Introduction
11.12.4 Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.12.5 Sanofi Oncology Recent Developments
11.13 Vertex Pharmaceuticals
11.13.1 Vertex Pharmaceuticals Company Details
11.13.2 Vertex Pharmaceuticals Business Overview
11.13.3 Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Introduction
11.13.4 Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.13.5 Vertex Pharmaceuticals Recent Developments
11.14 WILEX AG
11.14.1 WILEX AG Company Details
11.14.2 WILEX AG Business Overview
11.14.3 WILEX AG JAK and PI3K Signaling Pathway Introduction
11.14.4 WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2017-2022)
11.14.5 WILEX AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PI3K
Table 3. Key Players of Janus Kinase Therapies (Inhibitors)
Table 4. Key Players of PI3K Therapies (Inhibitors)
Table 5. Key Players of Signal Transduction Biomarkers for JAK and PI3K
Table 6. Global JAK and PI3K Signaling Pathway Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global JAK and PI3K Signaling Pathway Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global JAK and PI3K Signaling Pathway Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global JAK and PI3K Signaling Pathway Market Share by Region (2017-2022)
Table 10. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global JAK and PI3K Signaling Pathway Market Share by Region (2023-2028)
Table 12. JAK and PI3K Signaling Pathway Market Trends
Table 13. JAK and PI3K Signaling Pathway Market Drivers
Table 14. JAK and PI3K Signaling Pathway Market Challenges
Table 15. JAK and PI3K Signaling Pathway Market Restraints
Table 16. Global JAK and PI3K Signaling Pathway Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global JAK and PI3K Signaling Pathway Revenue Share by Players (2017-2022)
Table 18. Global Top JAK and PI3K Signaling Pathway by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in JAK and PI3K Signaling Pathway as of 2021)
Table 19. Ranking of Global Top JAK and PI3K Signaling Pathway Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by JAK and PI3K Signaling Pathway Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players JAK and PI3K Signaling Pathway Product Solution and Service
Table 23. Date of Enter into JAK and PI3K Signaling Pathway Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2017-2022)
Table 27. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global JAK and PI3K Signaling Pathway Revenue Market Share by Type (2023-2028)
Table 29. Global JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2017-2022)
Table 31. Global JAK and PI3K Signaling Pathway Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global JAK and PI3K Signaling Pathway Revenue Share by Application (2023-2028)
Table 33. North America JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America JAK and PI3K Signaling Pathway Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America JAK and PI3K Signaling Pathway Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America JAK and PI3K Signaling Pathway Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America JAK and PI3K Signaling Pathway Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe JAK and PI3K Signaling Pathway Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe JAK and PI3K Signaling Pathway Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe JAK and PI3K Signaling Pathway Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe JAK and PI3K Signaling Pathway Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific JAK and PI3K Signaling Pathway Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America JAK and PI3K Signaling Pathway Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America JAK and PI3K Signaling Pathway Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America JAK and PI3K Signaling Pathway Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa JAK and PI3K Signaling Pathway Market Size by Country (2023-2028) & (US$ Million)
Table 63. Bayer HealthCare Pharmaceuticals Company Details
Table 64. Bayer HealthCare Pharmaceuticals Business Overview
Table 65. Bayer HealthCare Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 66. Bayer HealthCare Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 67. Bayer HealthCare Pharmaceuticals Recent Developments
Table 68. AbbVie Company Details
Table 69. AbbVie Business Overview
Table 70. AbbVie JAK and PI3K Signaling Pathway Product
Table 71. AbbVie Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 72. AbbVie Recent Developments
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca JAK and PI3K Signaling Pathway Product
Table 76. AstraZeneca Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 77. AstraZeneca Recent Developments
Table 78. Curis Company Details
Table 79. Curis Business Overview
Table 80. Curis JAK and PI3K Signaling Pathway Product
Table 81. Curis Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 82. Curis Recent Developments
Table 83. Daiichi Sankyo Company Details
Table 84. Daiichi Sankyo Business Overview
Table 85. Daiichi Sankyo JAK and PI3K Signaling Pathway Product
Table 86. Daiichi Sankyo Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 87. Daiichi Sankyo Recent Developments
Table 88. Exelixis Company Details
Table 89. Exelixis Business Overview
Table 90. Exelixis JAK and PI3K Signaling Pathway Product
Table 91. Exelixis Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 92. Exelixis Recent Developments
Table 93. Genentech Company Details
Table 94. Genentech Business Overview
Table 95. Genentech JAK and PI3K Signaling Pathway Product
Table 96. Genentech Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 97. Genentech Recent Developments
Table 98. Infinity Pharmaceuticals Company Details
Table 99. Infinity Pharmaceuticals Business Overview
Table 100. Infinity Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 101. Infinity Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 102. Infinity Pharmaceuticals Recent Developments
Table 103. Merck & Co. Company Details
Table 104. Merck & Co. Business Overview
Table 105. Merck & Co. JAK and PI3K Signaling Pathway Product
Table 106. Merck & Co. Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 107. Merck & Co. Recent Developments
Table 108. Rigel Pharmaceuticals Company Details
Table 109. Rigel Pharmaceuticals Business Overview
Table 110. Rigel Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 111. Rigel Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 112. Rigel Pharmaceuticals Recent Developments
Table 113. TG Therapeutics Company Details
Table 114. TG Therapeutics Business Overview
Table 115. TG Therapeutics JAK and PI3K Signaling Pathway Product
Table 116. TG Therapeutics Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 117. TG Therapeutics Recent Developments
Table 118. Sanofi Oncology Company Details
Table 119. Sanofi Oncology Business Overview
Table 120. Sanofi Oncology JAK and PI3K Signaling Pathway Product
Table 121. Sanofi Oncology Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 122. Sanofi Oncology Recent Developments
Table 123. Vertex Pharmaceuticals Company Details
Table 124. Vertex Pharmaceuticals Business Overview
Table 125. Vertex Pharmaceuticals JAK and PI3K Signaling Pathway Product
Table 126. Vertex Pharmaceuticals Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 127. Vertex Pharmaceuticals Recent Developments
Table 128. WILEX AG Company Details
Table 129. WILEX AG Business Overview
Table 130. WILEX AG JAK and PI3K Signaling Pathway Product
Table 131. WILEX AG Revenue in JAK and PI3K Signaling Pathway Business (2017-2022) & (US$ Million)
Table 132. WILEX AG Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global JAK and PI3K Signaling Pathway Market Share by Type: 2021 VS 2028
Figure 2. PI3K Features
Figure 3. Janus Kinase Therapies (Inhibitors) Features
Figure 4. PI3K Therapies (Inhibitors) Features
Figure 5. Signal Transduction Biomarkers for JAK and PI3K Features
Figure 6. Global JAK and PI3K Signaling Pathway Market Share by Application: 2021 VS 2028
Figure 7. Cancer Case Studies
Figure 8. Inflammatory Diseases Case Studies
Figure 9. Cardiac Ailments Case Studies
Figure 10. Others Case Studies
Figure 11. JAK and PI3K Signaling Pathway Report Years Considered
Figure 12. Global JAK and PI3K Signaling Pathway Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global JAK and PI3K Signaling Pathway Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global JAK and PI3K Signaling Pathway Market Share by Region: 2021 VS 2028
Figure 15. Global JAK and PI3K Signaling Pathway Market Share by Players in 2021
Figure 16. Global Top JAK and PI3K Signaling Pathway Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in JAK and PI3K Signaling Pathway as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by JAK and PI3K Signaling Pathway Revenue in 2021
Figure 18. North America JAK and PI3K Signaling Pathway Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America JAK and PI3K Signaling Pathway Market Size Market Share by Type (2017-2028)
Figure 20. North America JAK and PI3K Signaling Pathway Market Size Market Share by Application (2017-2028)
Figure 21. North America JAK and PI3K Signaling Pathway Market Size Share by Country (2017-2028)
Figure 22. United States JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe JAK and PI3K Signaling Pathway Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe JAK and PI3K Signaling Pathway Market Size Market Share by Type (2017-2028)
Figure 26. Europe JAK and PI3K Signaling Pathway Market Size Market Share by Application (2017-2028)
Figure 27. Europe JAK and PI3K Signaling Pathway Market Size Share by Country (2017-2028)
Figure 28. Germany JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific JAK and PI3K Signaling Pathway Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific JAK and PI3K Signaling Pathway Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific JAK and PI3K Signaling Pathway Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific JAK and PI3K Signaling Pathway Market Size Share by Region (2017-2028)
Figure 38. China JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America JAK and PI3K Signaling Pathway Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America JAK and PI3K Signaling Pathway Market Size Market Share by Type (2017-2028)
Figure 46. Latin America JAK and PI3K Signaling Pathway Market Size Market Share by Application (2017-2028)
Figure 47. Latin America JAK and PI3K Signaling Pathway Market Size Share by Country (2017-2028)
Figure 48. Mexico JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa JAK and PI3K Signaling Pathway Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa JAK and PI3K Signaling Pathway Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa JAK and PI3K Signaling Pathway Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa JAK and PI3K Signaling Pathway Market Size Share by Country (2017-2028)
Figure 54. Turkey JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE JAK and PI3K Signaling Pathway Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 58. AbbVie Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 60. Curis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 61. Daiichi Sankyo Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 62. Exelixis Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 63. Genentech Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 64. Infinity Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 65. Merck & Co. Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 66. Rigel Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 67. TG Therapeutics Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 68. Sanofi Oncology Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 69. Vertex Pharmaceuticals Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 70. WILEX AG Revenue Growth Rate in JAK and PI3K Signaling Pathway Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
